COLIZZI, Marco
 Distribuzione geografica
Continente #
AS - Asia 3.854
NA - Nord America 2.078
EU - Europa 1.240
SA - Sud America 700
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.948
Nazione #
SG - Singapore 2.468
US - Stati Uniti d'America 1.961
BR - Brasile 579
IT - Italia 501
CN - Cina 493
HK - Hong Kong 369
VN - Vietnam 245
RU - Federazione Russa 208
DE - Germania 102
IE - Irlanda 96
GB - Regno Unito 59
CA - Canada 57
KR - Corea 56
IN - India 55
AR - Argentina 49
FI - Finlandia 41
NL - Olanda 39
BD - Bangladesh 38
AT - Austria 36
MX - Messico 36
FR - Francia 25
EC - Ecuador 24
ES - Italia 23
PL - Polonia 21
ID - Indonesia 20
DK - Danimarca 19
TR - Turchia 18
CO - Colombia 17
BE - Belgio 13
ZA - Sudafrica 13
IL - Israele 12
JP - Giappone 12
TG - Togo 12
IQ - Iraq 11
PK - Pakistan 11
SE - Svezia 10
UZ - Uzbekistan 10
MA - Marocco 9
AU - Australia 7
CL - Cile 7
EG - Egitto 7
JO - Giordania 7
PY - Paraguay 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
RS - Serbia 6
UA - Ucraina 6
BG - Bulgaria 5
HN - Honduras 5
PA - Panama 5
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
PE - Perù 4
TN - Tunisia 4
AO - Angola 3
GY - Guiana 3
LK - Sri Lanka 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
BN - Brunei Darussalam 2
DM - Dominica 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
MU - Mauritius 2
NP - Nepal 2
PH - Filippine 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 7.943
Città #
Singapore 545
Hong Kong 366
Ashburn 250
Beijing 250
Chandler 250
Boardman 139
Ho Chi Minh City 98
Dublin 94
Los Angeles 92
Princeton 84
Dallas 82
São Paulo 66
Milan 60
Hefei 56
Redondo Beach 56
Seoul 56
Rome 54
The Dalles 54
Buffalo 47
Hanoi 46
Toronto 39
Andover 30
Trieste 29
New York 26
Nuremberg 26
Chicago 22
Hyderabad 21
Lappeenranta 21
Vienna 21
Ogden 20
Santa Clara 20
Copenhagen 18
Frankfurt am Main 18
Munich 18
Rio de Janeiro 17
Brooklyn 16
Denver 16
Düsseldorf 16
Warsaw 16
Helsinki 15
Mexico City 15
Council Bluffs 14
Brasília 13
Brussels 13
Ningbo 13
Venice 13
Lomé 12
Udine 12
Haiphong 11
Tokyo 11
Atlanta 10
Istanbul 10
Montreal 10
Orem 10
Porto Alegre 10
Portsmouth 10
Stockholm 10
Verona 10
Amsterdam 9
Boston 9
Campinas 9
Johannesburg 9
Naples 9
Can Tho 8
Curitiba 8
Da Nang 8
Guayaquil 8
London 8
Poplar 8
Porcia 8
Seattle 8
Tashkent 8
Dhaka 7
Houston 7
Mumbai 7
Quito 7
Shanghai 7
Spinea 7
Belluno 6
Belo Horizonte 6
Bergamo 6
Chennai 6
Florence 6
Guangzhou 6
Guarulhos 6
Hải Dương 6
Pune 6
Ribeirão Preto 6
Santo André 6
São Bernardo do Campo 6
Tel Aviv 6
Treviso 6
Turin 6
Ankara 5
Baghdad 5
Belgrade 5
Charlotte 5
Columbus 5
Dongguan 5
Lauterbourg 5
Totale 3.661
Nome #
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 256
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 251
Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study 189
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 179
Challenges in addressing youth mental health 174
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages 173
Impact of COVID-19 on behavior in autism spectrum disorder 171
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 104
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 100
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 88
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 83
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 81
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 80
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 80
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 80
Disturbi d’ansia 79
CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL) 77
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 74
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 72
Cannabis use and the development of tolerance: a systematic review of human evidence 72
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 71
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 70
Editorial: Case reports in autism 69
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 69
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 68
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 68
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence 66
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 66
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example 65
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 65
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 63
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 62
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 62
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 62
Neurobiological underpinnings of the effects of cannabinoids 61
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 61
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 61
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 60
Tic-Related Obsessive-Compulsive and Eating Disorders in Dandy-Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles 60
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 59
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 59
Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study 58
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 57
Evidence for endocannabinoid-like compound supplementation for human health 56
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 56
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate “simplex” and “complex” phenotypes 55
Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations 55
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 55
Cannabis and psychosis: What do we know and what should we do? 55
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 55
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience 53
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 53
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 52
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 52
Prevention in Mental Health: From Risk Management to Early Intervention 51
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood 51
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 51
Expert consensus riguardante cannabis, cannabinoidi e prodotti derivati 51
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 51
Un adolescente con insolita sintomatologia ai tempi del COVID-19 50
Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk 50
Editorial: Methods and applications in addiction psychiatry research: 2021 50
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with tourette syndrome: Preliminary evidence from a case series 50
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 50
Prevalence and risk factors for depression in factitious disorder: a systematic review 49
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses 48
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 48
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 48
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis 48
Cannabis and Psychosis 47
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 47
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 47
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy 46
Psico-oncologia e psichiatria in medicina palliativa 46
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study 46
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 46
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 46
Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study 46
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 45
Cannabidiol (CBD) Listed as a Drug of Abuse by the Italian Health Ministry: Expert Opinion 45
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 44
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 44
Substance use, medication adherence and outcome one year following a first episode of psychosis 44
Cannabis: Neuropsychiatry and its effects on brain and behavior 44
Neurodevelopmental Disorders and Psychosocial Issues Later in Life 43
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents 43
The Moderating Role of Genetic and Environmental Risk Factors for Schizophrenia on the Relationship between Autistic Traits and Psychosis Expression in the General Population 43
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 43
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 43
Differential gene expression analysis in blood of first episode psychosis patients 43
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 42
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 42
Lo stigma nella salute mentale 42
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis 41
Psychological Interventions Tailored to the Needs of Individuals With Hearing and Visual Impairments: What Do We Know and What Should We Do? A Commentary on “A Systematic Review and Meta-Analysis of Psychological Interventions for Persons With Hearing or Vision Impairment: Research Gaps and Call to Action” 41
Introduction 41
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 41
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 41
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 41
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 41
Totale 6.622
Categoria #
all - tutte 46.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023745 87 13 27 88 63 177 34 56 93 35 43 29
2023/2024458 47 40 14 12 29 20 37 91 42 44 41 41
2024/20253.796 106 151 146 99 85 184 214 190 347 258 900 1.116
2025/20262.953 451 470 493 590 729 220 0 0 0 0 0 0
Totale 8.415